探索新生儿低血糖症的长期影响,以确定葡萄糖度的安全门
Meena Garg1, Sherin U Devaskar2
1Department of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
European journal of pediatrics
|March 22, 2025
概括
新生儿低血糖症的管理受到争论,持续的葡萄糖监测提供了有前途的早期检测和干预,以预防脑损伤. 优化定义和治疗对于更好的神经发育结果至关重要.
科学领域:
- 新生儿科学 新生儿科学
- 内分泌学 在内分泌学.
- 神经科学是一个神经科学.
背景情况:
- 新生儿低血糖是常见的,带来神经损伤和发育迟缓的风险.
- 目前新生儿低血糖症的诊断门缺乏共识,使管理复杂化.
- 低血糖症的症状可以模仿其他疾病,导致诊断延迟或错过.
研究的目的:
- 审查新生儿低血糖症定义中的争议.
- 介绍与新生儿低血糖相关的神经发育结果的最新发现.
- 讨论早期查和治疗对新生儿脑损伤的影响.
主要方法:
- 对新生儿低血糖症当前定义和诊断挑战的文献综述.
- 对最近关于葡萄糖值和神经发育结果的研究进行分析.
- 评估用于新生儿血糖评估的持续血糖监测 (CGM).
主要成果:
- 关于预防低血糖引起的脑损伤的最佳葡萄糖值的争论仍在继续.
- 在无症状的新生儿中,血糖水平在36-47 mg/dL之间可能是可以接受的;然而,在36 mg/dL以下,注意到伤害.
- 持续的葡萄糖监测揭示了血糖可变性,有助于早期识别和治疗新生儿低血糖症.
结论:
- 优化新生儿失糖症的定义和治疗方法对于预防脑损伤至关重要.
- 持续的葡萄糖监测技术为实时查和新生儿早期干预提供了一个有希望的途径.
- 需要进一步研究强大的临床设计,以澄清干预措施对长期神经发育结果的影响.
相关概念视频
Pathophysiology of Diabetes
837
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
837
Hypoglycemia and Glucagon
146
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
146
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Diabetes: Symptoms, Diagnosis, and Complications
494
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
494
Glucose Transporters
22.3K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.3K
Inborn Errors of Metabolism
120
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
120


